{
  "data": [
    {
      "question": "What is the minimum inhibitory concentration (MIC) of the bismuth(III) complex against Helicobacter pylori?",
      "answer": "6.25 lg mL-1",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What reaction results in the formation of the bismuth(III) complex [Bi(O2C(C6H4)OAc)3]N 1?",
      "answer": "Reaction of Bi(OtBu)3 with aspirin in dry toluene.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What is the yield percentage of [Bi(asp)3]N 1 when synthesized from Bi(OtBu)3 and aspirin?",
      "answer": "70%",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "Does the inclusion of a stoichiometric equivalent of KOtBu lead to the formation of a different compound from the bismuth(III) complex?",
      "answer": "Yes, it leads to crystals of the bismuthate salt [KBi(O2C(C6H4)OAc)4]N 2.",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the effect of aspirin on COX-1 and COX-2 enzymes?",
      "answer": "It acts irreversibly by deactivating both COX-1 and COX-2 enzymes.",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What is the main drawback of consistent ingestion of aspirin?",
      "answer": "A greater risk of upper-gastrointestinal bleeding.",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "Is the bismuth(III) acetylsalicylate complex more effective against H. pylori than aspirin alone?",
      "answer": "Yes, the bismuth complex shows far greater bactericidal activity.",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the yield of [KBi(asp)4]N 2 when synthesized?",
      "answer": "71%",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "Can the bismuth(III) acetylsalicylate complex potentially provide both therapeutic effects of aspirin and gastrointestinal protection?",
      "answer": "Yes, it could provide both the desirable therapeutic and preventative effects of aspirin while providing gastrointestinal protection.",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "What is the coordination number of each bismuth centre in the dimer of [Bi(asp)3]N 1?",
      "answer": "Seven in the dimer and increased to eight through polymerization.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What is the coordination number of each bismuth in the complex [KBi(asp)4]N 2?",
      "answer": "Nine",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "Does the complex [KBi(asp)4]N 2 form a polymeric structure in the solid state?",
      "answer": "Yes, it adopts a polymeric structure in the solid state.",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the role of aspirin in low doses?",
      "answer": "It functions as an anti-platelet agent, preventing heart attack and blood-clotting.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "Is the reaction of Bi(OtBu)3 with aspirin in dry toluene solvent-free?",
      "answer": "No, it is not solvent-free as it uses dry toluene.",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What happens to both complexes 1 and 2 in weakly acidic media?",
      "answer": "Both complexes decompose quickly in weakly acidic media.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "What is the effect of the bismuth(III) acetylsalicylate complex on the acidic OH absorption in the infrared spectra?",
      "answer": "The acidic OH absorption is absent in the infrared spectra of the complex.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What is the significance of the value of Du (u CO2 (asymm) - u CO2 (symm)) in both 1 and 2 being less than 200 cm-1?",
      "answer": "It indicates a bidentate chelating mode of the ligand consistent with the solid state structural analysis.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "Is the antibacterial activity of aspirin in its free acid form against H. pylori greater than the bismuth(III) complex?",
      "answer": "No, aspirin in its free acid form is found to be inactive (>25 mg mL-1) against H. pylori compared to the bismuth(III) complex.",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the role of Bi(OtBu)3 in the synthesis of the bismuth(III) complex?",
      "answer": "Bi(OtBu)3 is employed as a stronger and more labile base under dry, inert conditions for the synthesis.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "Does the bismuth(III) acetylsalicylate complex decompose in polar and non-polar media?",
      "answer": "Yes, it decomposes slowly in polar and non-polar media over several weeks.",
      "difficulty": "easy",
      "type": "True or False"
    }
  ]
}
